These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17606307)
1. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome. Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307 [TBL] [Abstract][Full Text] [Related]
2. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome]. Yang XF; Ren FR; Guo SP Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463 [TBL] [Abstract][Full Text] [Related]
3. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
4. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221 [TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome in young Korean women with polycystic ovary syndrome. Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984 [TBL] [Abstract][Full Text] [Related]
7. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome. Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799 [TBL] [Abstract][Full Text] [Related]
8. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143 [TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of insulin action in polycystic ovary syndrome. Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113 [TBL] [Abstract][Full Text] [Related]
10. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome. Takeuchi T; Tsutsumi O; Taketani Y Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711 [TBL] [Abstract][Full Text] [Related]
11. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome. Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186 [TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512 [TBL] [Abstract][Full Text] [Related]
13. [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance]. Calvar CE; Intebi AD; Bengolea SV; Hermes R; Spinedi E Medicina (B Aires); 2003; 63(6):704-10. PubMed ID: 14719312 [TBL] [Abstract][Full Text] [Related]
14. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Svendsen PF; Nilas L; Madsbad S; Holst JJ Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579 [TBL] [Abstract][Full Text] [Related]
15. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Carmina E; Lobo RA Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711 [TBL] [Abstract][Full Text] [Related]
16. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome]. Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903 [TBL] [Abstract][Full Text] [Related]
17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418 [TBL] [Abstract][Full Text] [Related]
18. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679 [TBL] [Abstract][Full Text] [Related]
19. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome. Bahceci M; Aydemir M; Tuzcu A Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944 [TBL] [Abstract][Full Text] [Related]
20. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome]. Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]